RELIEF THERAPEUTICS Holding AG / Key word(s): Conference27-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SI.
CAMBRIDGE, Mass., Jan. 07, 2022 Foghorn® Therapeutics Inc. , a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies. | January 7, 2022
/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for.